A Stopping Guideline for Pulmonary Heart Valve Premarket Approval Studies.

Authors

Hsin-Fang Li, Medical Data Research Center, Providence Health and Service, Portland, OregonFollow
YingXing Wu, Medical Data Research Center, Providence Health and Service, Portland, Oregon
M Wang, Medical Data Research Center, Providence Health and Services, Portland, OR, USAFollow
Gary GrunkemeierFollow

Document Type

Article

Publication Date

1-1-2018

Publication Title

Seminars in thoracic and cardiovascular surgery

Keywords

Bayes Theorem; Clinical Trials Data Monitoring Committees; Device Approval; Guideline Adherence; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Humans; Postoperative Complications; Practice Guidelines as Topic; Prosthesis Design; Pulmonary Valve; Risk Factors; Time Factors; Treatment Outcome; United States; United States Food and Drug Administration; cards

Clinical Institute

Cardiovascular (Heart)

Department

Cardiology

Department

Center for Cardiovascular Analytics, Research + Data Science (CARDS)

Recommended Citation

Li, Hsin-Fang; Wu, YingXing; Wang, M; and Grunkemeier, Gary, "A Stopping Guideline for Pulmonary Heart Valve Premarket Approval Studies." (2018). Articles, Abstracts, and Reports. 1745.
https://digitalcommons.providence.org/publications/1745